A new FDA tool aims to inform cancer care, but experts say it has a glaring gap
ADOBE
The platform gives cancer patients and physicians a way to comb through data on the experiences of clinical trial participants.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario